- Home
- NBIX vs CR Comparison
NBIX vs CR Comparison
Compare NBIX & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- CR
- Stock Information
- Founded
- NBIX 1992
- CR 1855
- Country
- NBIX United States
- CR United States
- Employees
- NBIX N/A
- CR N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- CR Metal Fabrications
- Sector
- NBIX Health Care
- CR Industrials
- Exchange
- NBIX Nasdaq
- CR Nasdaq
- Market Cap
- NBIX 12.4B
- CR 10.9B
- IPO Year
- NBIX 1996
- CR N/A
- Fundamental
- Price
- NBIX $134.33
- CR $186.84
- Analyst Decision
- NBIX Strong Buy
- CR Strong Buy
- Analyst Count
- NBIX 21
- CR 4
- Target Price
- NBIX $165.14
- CR $197.75
- AVG Volume (30 Days)
- NBIX 821.3K
- CR 350.5K
- Earning Date
- NBIX 07-30-2025
- CR 07-28-2025
- Dividend Yield
- NBIX N/A
- CR 0.50%
- EPS Growth
- NBIX N/A
- CR 54.50
- EPS
- NBIX 2.96
- CR 5.76
- Revenue
- NBIX $2,412,600,000.00
- CR $2,178,600,000.00
- Revenue This Year
- NBIX $16.29
- CR $10.22
- Revenue Next Year
- NBIX $15.08
- CR $11.07
- P/E Ratio
- NBIX $45.11
- CR $32.17
- Revenue Growth
- NBIX 21.73
- CR 17.22
- 52 Week Low
- NBIX $84.23
- CR $127.04
- 52 Week High
- NBIX $157.98
- CR $195.00
- Technical
- Relative Strength Index (RSI)
- NBIX 70.92
- CR 55.46
- Support Level
- NBIX $127.03
- CR $186.53
- Resistance Level
- NBIX $135.94
- CR $195.00
- Average True Range (ATR)
- NBIX 2.85
- CR 4.15
- MACD
- NBIX 0.47
- CR -0.39
- Stochastic Oscillator
- NBIX 87.52
- CR 56.47
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.